Lynette Keyes-Elstein

2.9k total citations
20 papers, 1.1k citations indexed

About

Lynette Keyes-Elstein is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lynette Keyes-Elstein has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Lynette Keyes-Elstein's work include Systemic Sclerosis and Related Diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Diabetes Management and Research (5 papers). Lynette Keyes-Elstein is often cited by papers focused on Systemic Sclerosis and Related Diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Diabetes Management and Research (5 papers). Lynette Keyes-Elstein collaborates with scholars based in United States. Lynette Keyes-Elstein's co-authors include Jayne Stuart, Peter A. Margolis, Ashley Pinckney, Mario R. Ehlers, Deborah Phippard, Peter A. Gottlieb, Jeffrey A. Bluestone, Stephen E. Gitelman, Sudeepta Aggarwal and Peter H. Sayre and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and Diabetes.

In The Last Decade

Lynette Keyes-Elstein

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynette Keyes-Elstein United States	13	441	385	358	271	237	20	1.1k
Fiona L. Dignan United Kingdom	22	90 0.2×	198 0.5×	64 0.2×	72 0.3×	123 0.5×	38	1.8k
Limin Yang Japan	20	58 0.1×	257 0.7×	109 0.3×	68 0.3×	203 0.9×	61	1.2k
Emily Ko United States	24	74 0.2×	428 1.1×	31 0.1×	80 0.3×	169 0.7×	186	2.1k
Courtney M.P. Hollowell United States	25	79 0.2×	450 1.2×	39 0.1×	239 0.9×	414 1.7×	90	1.5k
Elizabeth H. Jones United Kingdom	12	73 0.2×	158 0.4×	57 0.2×	72 0.3×	202 0.9×	39	1.2k
Ashish Patel United States	18	360 0.8×	354 0.9×	18 0.1×	42 0.2×	113 0.5×	56	1.2k
Joseph Stanek United States	18	135 0.3×	136 0.4×	36 0.1×	42 0.2×	123 0.5×	151	1.3k
Konstantinos Dinas Greece	21	74 0.2×	254 0.7×	52 0.1×	50 0.2×	70 0.3×	152	1.6k
James Young Canada	20	55 0.1×	614 1.6×	232 0.6×	125 0.5×	244 1.0×	50	1.2k
Joel E. Goldberg United States	20	66 0.1×	690 1.8×	88 0.2×	96 0.4×	311 1.3×	78	1.3k

Countries citing papers authored by Lynette Keyes-Elstein

Since Specialization

Citations

This map shows the geographic impact of Lynette Keyes-Elstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette Keyes-Elstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette Keyes-Elstein more than expected).

Fields of papers citing papers by Lynette Keyes-Elstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette Keyes-Elstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette Keyes-Elstein. The network helps show where Lynette Keyes-Elstein may publish in the future.

Co-authorship network of co-authors of Lynette Keyes-Elstein

This figure shows the co-authorship network connecting the top 25 collaborators of Lynette Keyes-Elstein. A scholar is included among the top collaborators of Lynette Keyes-Elstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynette Keyes-Elstein. Lynette Keyes-Elstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ayoglu, Burcu, Michele Donato, Daniel E. Furst, et al.. (2023). Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. 82(5). 670–680. 10 indexed citations

Adamska, Julia Z., Amin Zia, Michelle S. Bloom, et al.. (2022). Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 82(3). 357–364. 11 indexed citations

Zamanian, Roham T., David B. Badesch, Leland W.K. Chung, et al.. (2021). Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 204(2). 209–221. 119 indexed citations

Keyes-Elstein, Lynette, Erica Brittain, Ashley Pinckney, Ellen Goldmuntz, & Keith M. Sullivan. (2020). Safety and efficacy of HSCT for systemic sclerosis across clinical trials. Nature Reviews Rheumatology. 16(11). 661–661. 3 indexed citations

Franks, Jennifer M., Viktor Martyanov, Yue Wang, et al.. (2020). Machine learning predicts stem cell transplant response in severe scleroderma. Annals of the Rheumatic Diseases. 79(12). 1608–1615. 28 indexed citations

Sullivan, Keith M. & Lynette Keyes-Elstein. (2020). Cross-trial comparisons in reviews: proceed with caution. Nature Reviews Rheumatology. 16(12). 663–664. 5 indexed citations

Zamanian, Roham T., David B. Badesch, Leland W.K. Chung, et al.. (2019). Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension. RCT1884–RCT1884. 6 indexed citations

Volkmann, Elizabeth R., Donald P. Tashkin, Myung‐Shin Sim, et al.. (2018). Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Annals of the Rheumatic Diseases. 78(1). 122–130. 137 indexed citations

Sim, Minyoung, DP Tashkin, Dhanita Khanna, et al.. (2017). OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up. Annals of the Rheumatic Diseases. 76. 104–104. 1 indexed citations

10.

Pinckney, Ashley, Mark Rigby, Lynette Keyes-Elstein, et al.. (2016). Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial. Clinical Therapeutics. 38(6). 1327–1339. 19 indexed citations

11.

Gitelman, Stephen E., Peter A. Gottlieb, Eric I. Felner, et al.. (2016). Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial. Diabetologia. 59(6). 1153–1161. 65 indexed citations

12.

Hagopian, William, et al.. (2014). Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders. eScholarship (California Digital Library). 16. 21 indexed citations

13.

Hall, Russell P., Janet A. Fairley, David T. Woodley, et al.. (2014). A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone. British Journal of Dermatology. 172(3). 760–768. 37 indexed citations

14.

Gitelman, Stephen E., Peter A. Gottlieb, Mark Rigby, et al.. (2013). Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. The Lancet Diabetes & Endocrinology. 1(4). 306–316. 97 indexed citations

15.

Herold, Kevan C., Stephen E. Gitelman, Mario R. Ehlers, et al.. (2013). Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial. Diabetes. 62(11). 3766–3774. 294 indexed citations

16.

Hosing, Chitra, Richard A. Nash, Peter A. McSweeney, et al.. (2010). Acute Kidney Injury in Patients with Systemic Sclerosis Participating in Hematopoietic Cell Transplantation Trials in the United States. Biology of Blood and Marrow Transplantation. 17(5). 674–681. 15 indexed citations

17.

Sullivan, K., D. H. Wallace, Peter A. McSweeney, et al.. (2008). Gastric antral vascular ectasia (GAVE) in early diffuse SSc: Report from the SCOT trial. Arthritis & Rheumatism. 58(9). 3 indexed citations

18.

Socolar, Rebecca R. S., et al.. (2005). Factors that Affect Parental Disciplinary Practices of Children Aged 12 to 19 Months. Southern Medical Journal. 98(12). 1181–1191. 12 indexed citations

19.

Margolis, Peter A., Carole Lannon, Jayne Stuart, et al.. (2004). Practice based education to improve delivery systems for prevention in primary care: randomised trial. BMJ. 328(7436). 388–388. 111 indexed citations

20.

Margolis, Peter A., R. Brian Stevens, W. Clayton Bordley, et al.. (2001). From Concept to Application: The Impact of a Community-Wide Intervention to Improve the Delivery of Preventive Services to Children. PEDIATRICS. 108(3). e42–e42. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact